Abbott launches novel coronavirus test

Create PDF

March 19, 2020—Abbott has received emergency use authorization from the FDA for its molecular test for the identification of SARS-CoV-2. The Abbott RealTime SARS-CoV-2 EUA test can be used on Abbott’s m2000 RealTime system by authorized laboratories in the U.S.

“Our scientists, many of whom worked on Abbott’s first HIV test and the Zika tests, worked around the clock to develop these molecular tests,” Daman Kowalski, vice president and head of molecular diagnostics, Abbott, said in a press statement. “Providing people at the frontlines of this pandemic with critical tests will help ensure proper care for patients and help protect our communities.”